Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRGO · against 356 other Healthcare companies of similar size
Ranked #292 of 357 · scores higher than 17% of peers
Bars: peers in each 10-point band of the growth score44 peers with a growth score of 20–29, including PRGO · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | PRGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 357 reported | -2.8% | 6.9% | 21% | 33% | |
| Earnings per share growthHigher is better · 205 reported | Not reported | 10.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 349 reported | -1.5% | 8.4% | 21% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 292 | 9.3B CNY (≈$1.3B) | 23 | 67 | |
| 292 | 10.5B CNY (≈$1.5B) | 23 | 66 | |
| 292 | 13.8B CNY (≈$1.9B) | 23 | 51 | |
| 292 | 22.4B CNY (≈$3.1B) | 23 | 62 | |
| 292 | 2.2B USD | 23 | 37 | |
| 297 | 9.2B CNY (≈$1.3B) | 22 | 53 | |
| 297 | 10.4B CNY (≈$1.5B) | 22 | 42 | |
| 297 | 1.7B USD | 22 | 44 | |
| 297 | 1.9B USD | 22 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score